SUBSCRIBE
SUBSCRIBE

Food and Drug Administration (FDA)

NEWS
Policy
FDA Misses Lessons of Device Recalls
June 24, 2011
 · 
1 min read
BioCapital
FDA: Silicone Breast Implants Relatively Safe; But Won’t Last for Life
June 23, 2011
 · 
1 min read
BioCapital
FDA: Medical Device Industry Tells Agency to Take a Time Out on User Fee Reauthorization
June 21, 2011
 · 
1 min read
BioCapital
Studies of FDA Criticized as Med-Tech Industry Spin
June 20, 2011
 · 
1 min read
Policy
Streamlined FDA Medical Device User Fee is Key for Senators
June 16, 2011
 · 
1 min read
Policy
Rep. Paulsen: FDA’s Device Regs Are Inconsistent
June 7, 2011
 · 
1 min read
FDA Warns Medical Device Companies Of Unexpected Industry Aftershocks From Japan’s Earthquake And Tsunami
June 3, 2011
 · 
1 min read
BioCapital
FDA Device Chief Shuren: Recession Played a Role In Pushing Medical Device Industry to EU
June 3, 2011
 · 
1 min read
BioCapital
FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
June 2, 2011
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
June 30, 2026
 · 
3 min read
Press Releases
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
June 30, 2026
 · 
5 min read
Press Releases
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
June 30, 2026
 · 
8 min read
Press Releases
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
June 29, 2026
 · 
6 min read
Press Releases
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
June 29, 2026
 · 
7 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
June 29, 2026
 · 
14 min read
Press Releases
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
June 29, 2026
 · 
14 min read
Press Releases
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
June 28, 2026
 · 
13 min read
Press Releases
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
June 28, 2026
 · 
4 min read
Press Releases
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 28, 2026
 · 
6 min read
Load More